Skip to content

Ins-biomarker Testing

It became law on Jul 30, 2021.

IL HB 1779 · House Bill · 102nd

Stage
Became law
Started in
House
Sponsors
60
Latest action
Jul 30, 2021

What it does

Amends the Illinois Insurance Code to provide that an individual or group health care service plan contract that is issued, amended, delivered, or renewed on or after January 1, 2022 shall not require prior authorization for biomarker testing for an insured with advanced or metastatic stage 3 or 4 cancer, nor shall prior authorization be required for biomarker testing of cancer progression or recurrence in the insured with advanced or metastatic stage 3 or 4 cancer. Defines "biomarker testing". House Committee Amendment No. 1 Adds reference to: 5 ILCS 375/6.11 55 ILCS 5/5-1069.3 65 ILCS 5/10-4-2.3 105 ILCS 5/10-22.3f 215 ILCS 125/5-3 from Ch. 111 1/2, par. 1411.2 215 ILCS 130/4003 from Ch.…

Read the full text

Where it stands

This bill passed and is now law.

  1. Introduced (Done)

  2. Committee (Done)

  3. Floor (Done)

  4. Law (Done)

    Jul 30, 2021

What moved

Loading recorded actions…

Who is involved

Sponsors

The lawmakers who put their names on it, lead sponsors first.

In the news

Reporting that may mention this subject. Possible matches are labeled.

Loading coverage…

Where it goes next

Once a bill is decided, the questions are about what is done with it in Illinois.

Work with this bill

INS-BIOMARKER TESTING | 52